Clinical Study results promising for CCT product

Results from a clinical study provide promising feasibility indications for Brain+’ CCT technology for cognitive training A study conducted by Nottingham University as part of the Brain+ led European Horizon2020 project called Alzheimer’s Detect & Prevent has provided promising feasibility indications that Computerized Cognitive Training (CCT) can positively impact the cognitive load in people with […]

Brain+ first municipal sale of its new dementia product

Brain+ closes 2022 with the first municipal sale of its new dementia product and begins the monetization journey Another milestone has been met by Brain+ as it closes the year with the first sale of its new dementia product, the CST-Therapist Companion to the municipality of Herning for their Training & Activity East facility. The […]

3-Year Innovation Project is Completed

3-year innovation project with the Danish Life Science Cluster is completed with the Brain+ CST-Therapist Companion product as the final output A 3-year collaboration project between VIA University College, MedTech Innovation Consortium (MTIC), and Brain+ has been completed. The project aimed to bring digital health solutions to people with dementia, in particular, solutions based on […]

Strong Q4 with Product Launch & Successful Capital Raise

Brain+ announces Investor Webinar  following strong Q4 with product launch and succesful capital raise Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful capital raise, and several supportive market news announcements Highlights of Q4 2022 Invitation to Brain+ Q4 investor webinar   Brain+ hosts an […]

Pilot with volunteers from DaneAge Association

Brain+ begins commercial pilot with volunteers from the DaneAge Association Brain+, a pioneer in the development of digital therapeutics for Alzheimer’s disease, is excited to announce the launch of a pilot project with DaneAge (Ældre Sagen) to test the use of the Brain+ CST-Therapist Companion to enable volunteers from the association to deliver Cognitive Stimulation Therapy (CST) to […]

Implementation of an ISO 13485 for Medical Devices

Brain+ completes the implementation of an ISO 13485 Quality Management System for Medical Devices Brain+ has successfully completed the implementation of an ISO 13485-compliant Quality Management System (QMS). Such a system helps to set standards to ensure stringent processes throughout every step of a medical device product’s life cycle and thus to maintain a high […]

WHO points to CST to solve the dementia burden

A new WHO report points to Cognitive Stimulation Therapy (CST) and digital solutions As means to help solve the global dementia burden The World Health Organization (WHO) recently published a large report, A blueprint For Dementia Research, as its first initiative of this kind in the context of non-infectious diseases. In the report, WHO refers to […]

Leading dementia researcher joins Brain+

Brain+ adds new clinical and development competences To accelerate and support market access of its digital dementia product portfolio Brain+ (BRAINP), a pioneer in the development of digital therapeutics for Alzheimer’s disease and dementia, has hired Nahid Zokaei to a new position as Clinical Director, Erik Esmann Poulsen to a new position as Quality Manager, […]

First milestone met

Brain+ meets milestone with Rox Health (Roche Germany) October 11, 2022 – Brain+, a pioneer in the development of digital therapeutics for Alzheimer’s disease and dementia, has met the first of three milestones in its partnership with Rox Health, the digital venture builder of Roche Germany The partnership was initiated in December 2021 to co-develop […]

Accelerated launch Q2 2023

Brain+ partners with German medical distributor Advances launch of its first CST dementia product in Germany to Q2 2023   Through Coopmed, Brain+ will be represented by experienced and local medical sales managers in Germany and begin to build the customer pipeline in preparation for the commercial launch of its first CST dementia product, CST-Therapist […]